Cytomegalovirus Modulates Transcription Factors Necessary for the Activation of the Tumor Necrosis Factor-α Promoter

American Journal of Respiratory Cell and Molecular Biology

Volumn 16, Issue 1, 1997, Pages 31-37

  Geist, Lois J ^a   Hopkins, Harvey A ^a   Dai, Lucia Y ^a   He, Bei ^a   Monick, Martha M ^a   Hunninghake, Gary W ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CUCUMBER MOSAIC VIRUS; CYTOMEGALOVIRUS;

CYCLIC AMP; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; IE1 PROTEIN, CYTOMEGALOVIRUS; IMMEDIATE EARLY PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ONCOPROTEIN; PROTO ONCOGENE PROTEIN SPI 1; PROTO-ONCOGENE PROTEIN SPI-1; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA; VIRUS PROTEIN;

ARTICLE; BIOSYNTHESIS; CELL CULTURE; CYTOMEGALOVIRUS; GENETICS; HUMAN; LUNG ALVEOLUS MACROPHAGE; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; PROMOTER REGION; VIROLOGY;

BASE SEQUENCE; CELLS, CULTURED; CYCLIC AMP; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; CYTOMEGALOVIRUS; HUMANS; IMMEDIATE-EARLY PROTEINS; MACROPHAGES, ALVEOLAR; MOLECULAR SEQUENCE DATA; NF-KAPPA B; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA; VIRAL PROTEINS;

EID: 0030638504     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.16.1.8998076     Document Type: Article

References (48)

1. Chatterjee, S. N., M. Fiala, J. Weiner, J. A. Stewart, B. Stacey, and N. Warner. 1978. Primary cytomegalovirus and opportunistic infections. Incidence in renal transplant recipients. JAMA 240:2446-2449.
2. Peterson, P. K., P. McGlave, N. K. C. Ramsay, F. Rhame, E. Cohen, G. S. Perry, A. I. Goldman, and J. Kersey. 1983. A prospective study of infectious diseases following bone marrow transplantation: emergence of Aspergillus and Cytomegalovirus as the major causes of mortality. Infect. Control 4:81-89.
3. Cohen, J. I., and G. R. Corey. 1985. Cytomegalovirus infection in the normal host. Medicine 64:100-114.
4. Meyers, J. D., N. Flourney, and E. D. Thomas. 1986. Risk factors for cytomegalovirus infection after human bone marrow transplantation. J. Infect. Dis. 153:478-488.
5. Fend, F., C. Prior, R. Margreiter, and G. Mikuz. 1990. Cytomegalovirus pneumonitis in heart-lung transplant recipients: histopathology and clinicopathologic considerations. Hum. Pathol. 21:918-926.
6. Duncan, S. R., I. L. Paradis, S. A. Yousem, S. L. Similo, W. F. Grgurich, P. A. Williams, J. H. Dauber, and B. P. Griffith. 1992. Sequelae of cytomegalovirus pulmonary infections in lung allograft recipients. Am. Rev. Respir. Dis. 146:1419-1425.
7. Ettinger, N. A., T. C. Bailey, E. P. Trulock, G. A. Storch, D. Anderson, S. Raab, E. L. Spitznagel, C. Dresler, and J. D. Cooper. 1993. Cytomegalovirus infection and pneumonitis: impact after isolated lung transplantation. Am. Rev. Respir. Dis. 147:1017-1023.
8. Beutler, B., D. Greenwald, J. D. Hulmes, M. Chang, Y.-C. E. Pan, J. Mathison, R. Ulevich, and A. Cerami. 1985. Identity of tumor necrosis factor and the macrophage-secreted factor cachectin. Nature 316:552-554.
9. Beutler, B., and A. Cerami. 1986. Cachetin and tumour necrosis factor as two sides of the same biological coin. Nature 320:584-587.
10. Beutler, B., and A. Cerami. 1988. Tumor necrosis factor, cachexia, shock and inflammation: a common mediator. Ann. Rev. Biochem. 57:505-518.
11. Remick, D. G., R. M. Streiter, M. K. Eskandari, D. T. Nguyen, M. A. Genord, C. L. Raiford, and S. L. Kunkel. 1990. Role of tumor necrosis factor-α in lipopolysaccharide-induced pathologic alterations. Am. J. Pathol. 136:49-60.
12. Dubois, C. M., R. Bissonnette, and M. Rola-Pleszczynski. 1989. Asbestos fibers and silica particles stimulate rat alveolar macrophages to release tumor necrosis factor. Am. Rev. Respir. Dis. 139:1257-1264.
13. Piguet, P. F., M. A. Collart, G. E. Grau, A.-P. Sappino, and P. Vassalli. 1990. Requirement of tumor necrosis factor for development of silica-induced pulmonary fibrosis. Nature 344:245-247.
14. Zhang, Y., T. C. Lee, B. Guillemin, M.-C. Yu, and W. N. Rom. 1993. Enhanced IL 1β and tumor necrosis factor-α release and messenger RNA expression in macrophages from idiopathic pulmonary fibrosis or after silica exposure. J. Immunol. 150:4188-4196.
15. Smith, P. D., S. S. Saini, M. Raffeld, J. F. Manischewitz, and S. M. Wahl. 1992. Cytomegalovirus induction of tumor necrosis factor-α by human monocytes and mucosal macrophages. J. Clin. Invest. 90:1642-1648.
16. Geist, L. J., M. M. Monick, M. F. Stinski, and G. W. Hunninghake. 1994. The immediate early genes of human cytomegalovirus upregulate tumor necrosis factor-α gene expression. J. Clin. Invest. 93:474-478.
17. Stinski, M. F. Cytomegalovirus and its replication. 1990. In Fields Virology, Vol. 2. Bernard N. Fields and David Knipe, editors. Raven Press, New York. 1959-1980.
18. Geist, L. J., M. M. Monick, M. F. Stinski, and G. W. Hunninghake. 1991. The immediate early genes of human cytomegalovirus upregulate expression of the interleukin-2 and interleukin-2 receptor genes. Am. J. Respir. Cell Mol. Biol. 5:292-296.
19. Hunninghake, G. W., B. G. Monks, L. J. Geist, M. M. Monick, M. F. Monroy, M. F. Stinski, A. C. Webb, J.-M. Dayer, P. E. Auron, and M. J. Fenton. 1992. The functional importance of a cap site-proximal region of the human prointerleukin 1β gene is defined by viral protein trans-activation. Mol. Cell. Biol. 12:3439-3448.
20. Iwamoto, G. K., M. M. Monick, B. D. Clark, P. E. Auron, M. F. Stinski, and G. W. Hunninghake. 1990. Modulation of interleukin 1 beta expression by the immediate early genes of human cytomegalovirus. J. Clin. Invest. 85:1853-1857.
21. Helmers, R. A. and G. W. Hunninghake. 1989. Bronchoalveolar lavage in the nonimmunocompromised patient. Chest 96:1184-1190.
22. Hermiston, T. W., C. L. Malone, P. R. Witte, and M. F. Stinski. 1987. Identification and characterization of the human cytomegalovirus immediate-early region 2 gene that stimulates gene expression from an inducible promoter. J. Virol. 61:3214-3221.
23. Stenberg, R. M., and M. F. Stinski. 1985. Autoregulation of the human cytomegalovirus major immediate early gene. J. Virol. 6:676-682.
24. Stinski, M. F., and T. J. Roehr. 1985. Activation of the major immediate early gene of human cytomegalovirus by cis-acting elements in the promoter-regulatory sequence and by virus specific trans-acting components. J. Virol. 55:431-441.
25. Goldfeld, A. E., C. Doyle, and T. Maniatis. 1990. Human tumor necrosis factor-α gene regulation by virus and lipopolysaccharide Proc. Natl. Acad. Sci. USA 87:9769-9773.
26. Goldfeld, A. E., P. G. McCaffrey, J. L. Strominger and A. Rao. 1993. Identification of a novel cyclosporin-sensitive element in the tumor necrosis factor-α gene promoter. J. Exp. Med. 178:1365-1379.
27. Gorman, C. M., L. F. Moffat, and B. H. Howard. 1982. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol. 2:1044-1051.
28. Digman, J. D., R. M. Lebovitz, and R. G. Roeder. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475-1489.
29. Nelsen, B., L. Hellman, and R. Sen. 1988. The NF-κB-binding site mediates phorbol ester-inducible transcription in nonlymphoid cells. Mol. Cell. Biol. 8:3526-3531.
30. 2+-regulated transcription factor phosphorylated by calmodulin-dependent kinases. Science 252:1427-1430.
31. Kramer, B., K. Wiegmann, and M. Kronke. 1995. Regulation of the human TNF promoter by the transcription factor ets. J. Biol. Chem. 270:6577-6583.
32. Wu, J., R. Jupp, R. M. Stenberg, J. A. Nelson, and P. Ghazal. 1993. Site-specific inhibition of RNA polymerase II preinitiation complex assembly by human cytomegalovirus IE86 protein. J. Virol. 67:7547-7555.
33. Jupp, R., S. Hoffmann, R. M. Stenberg, J. A. Nelson, and P. Ghazal. 1993. Human cytomegalovirus IE86 protein interacts with promoter-bound TATA-binding protein via a specific region distinct from the autorepressor region. J. Virol. 67:7539-7546.
34. Leitman, D. L., R. C. J. Ribeiro, E. R. Mackow, J. D. Baxter, and B. L. West. 1991. Identification of a tumor necrosis factor-responsive element in the tumor necrosis factor α gene. J. Biol. Chem. 266:9343-9346.
35. Hunninghake, G. W., M. M. Monick, B. Lui, and M. F. Stinski. 1989. The promoter-regulatory region of the major immediate-early gene of human cytomegalovirus responds to T-lymphocyte stimulation and contains functional cyclic AMP-response elements. J. Virol. 63:3026-3033.
36. 1ax of human T-cell leukemia virus type I via two repetitive tax-responsive sequence elements. J. Virol. 66:7346-7354.
37. Du, W. and T. Maniatis. 1992. An ATF/CREB binding site protein is required for virus induction of the human interferon β gene. Proc. Natl. Acad. Sci. USA 89:2150-2154.
38. Horiguchi, M., R. E. Pratt, N. Nakamura, and V. J. Dzau. 1993. Distinct nuclear proteins competing for an overlapping sequence of cyclic adenosine monophosphate and negative regulatory elements regulate tissue-specific mouse renin gene expression. J. Clin. Invest. 92:1805-1811.
39. Franklin, A. A., M. F. Kubik, M. N. Uittenbogaard, A Brauweiler, P. Utainsincharoen, M.-A. H. Matthews, W. S. Dynan, J. P. Hoeffler, and J. K. Nyborg. 1993. Transactivation by the human T-cell leukemia virus tax protein is mediated through enhanced binding of activating transcription factor-2 (ATF-2), ATF-2 response and cAMP element-binding protein (CREB). J. Biol. Chem. 268:21225-21231.
40. Buras, J. A., W. R. Reenstra, and M. J. Fenton. 1995. NFβA, a factor required for maximal IL-1β gene expression is identical to the ets family member PU.1. Evidence of structural alteration following LPS activation. Molecular Immunology 32:541-554.
41. Collart, M. A., P. Baeuerle, and P. Vassalli. 1990. Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four κ B-like motifs and of constitutive and inducible forms of NF-κB. Mol. Cell. Biol. 10:1498-1506.
42. Economou, J. S., K. Rhoades, R. Essner, W. H. McBride, J. C. Gasson, and D. L. Morton. 1989. Genetic analysis of the human tumor necrosis factor α/cachectin promoter region in a macrophage cell line. J. Exp. Med. 170:321-326.
43. Albrecht, H., A. N. Shakhov, and C. V. Jongeneel. 1992. trans activation of the tumor necrosis factor alpha promoter by the human T-cell leukemia virus type I Tax protein. J. Virol. 66:6191-6193.
44. Merrill, J. E., Y. Koyanagi, and I. S. Y. Chen. 1989. Interleukin-1 and tumor necrosis factor can be induced from mononuclear phagocytes by human immunodeficiency virus type I binding to the CD4 receptor J. Virol. 63:4404-4408.
45. Munis, J. R., D. D. Richman, and R. S. Kornbluth. 1990. Human immunodeficiency virus-1 infection of macrophages in vitro neither induces tumor necrosis factor (TNF)/cachectin gene expression nor alters TNF/ cachectin induction by lipopolysaccharide. J. Clin. Invest. 85:591-596.
46. Aderka, D., H. Holtzmann, L. Toker, T. Hahn, and D. Wallach. 1986. Tumor necrosis factor induction by Sendai virus. J. Immunol. 136:2938-2942.
47. Becker, S., S. Quay, and J. Soukup. 1991. Cytokine (tumor necrosis factor, IL-6, and 1L-8) production by respiratory syncytial virus-infected human alveolar macrophages. J. Immunol. 147:4307-4312.
48. Vacheron, F., A. Rudent, S. Perin, C. Labarre, A. M. Quero, and M. Guenounou. 1990. Production of interleukin I and tumor necrosis factor activities in bronchoalveolar washings following infection of mice by influenza virus. J. Gen. Virol. 71:477-479.